OMRON Corporation
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 11 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/02/04 | ¥56.74 | ¥26.91 | -52.6% |
| 2025/11/06 | ¥40.60 | ¥11.34 | -72.1% |
| 2025/08/05 | ¥27.93 | ¥34.62 | +24.0% |
| 2025/05/08 | ¥61.80 | ¥46.16 | -25.3% |
Shareholder Composition
Updated 2026/08/01Top Mutual Funds / ETFs
Updated 2026/08/01Major Holders
Updated 2026/08/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.8M | +0.50% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.8M | +2.58% | |
|
GLOBAL X FUNDS-Global X Robotics & Artificial Intelligence ETF
|
1.6M | -0.15% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.3M | 0.00% | |
|
VANGUARD TRUSTEES' EQUITY FUND-Vanguard International Value Fund
|
1.2M | -1.94% | |
|
Artisan Partners Funds Inc.-Artisan International Small-Mid Fund
|
1.1M | +1.00% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
374 | +73.95% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥52 | -50.0% |
| 2025 | ¥104 | 0.0% |
| 2024 | ¥104 | +3.0% |
| 2023 | ¥101 | +6.3% |
| 2022 | ¥95 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥762,927M | ¥876,082M | ¥818,761M | ¥801,753M |
| Gross Profit | ¥346,827M | ¥393,883M | ¥346,464M | ¥357,142M |
| Operating Income | ¥86,714M | ¥98,409M | ¥34,953M | ¥56,782M |
| Pretax Income | ¥86,714M | ¥98,409M | ¥34,953M | ¥56,782M |
| Net Income | ¥61,400M | ¥73,861M | ¥8,105M | ¥16,271M |
| EPS | ¥305.65 | ¥372.19 | ¥41.17 | ¥82.63 |
| Operating Margin | 11.37% | 11.23% | 4.27% | 7.08% |
| Balance Sheet | ||||
| Total Assets | ¥930,629M | ¥998,160M | ¥1,354,729M | ¥1,361,790M |
| Total Equity | ¥665,227M | ¥728,473M | ¥786,686M | ¥771,885M |
| Total Liabilities | ¥265,402M | ¥269,687M | ¥568,043M | ¥589,905M |
| Cash | ¥155,484M | ¥105,279M | ¥143,086M | ¥149,023M |
| Interest-bearing Debt | ¥60,116M | ¥45,368M | ¥172,758M | ¥184,203M |
| Equity Ratio | 71.48% | 72.98% | 58.07% | 56.68% |
| D/E Ratio | 0.09 | 0.06 | 0.22 | 0.24 |
| Cash Flow | ||||
| Operating CF | ¥67,428M | ¥53,456M | ¥44,875M | ¥55,784M |
| Investing CF | -¥150,163M | -¥55,533M | -¥107,096M | -¥47,889M |
| Financing CF | -¥29,603M | -¥58,757M | ¥85,987M | -¥4,608M |
| Free CF | ¥34,071M | ¥8,438M | -¥503M | ¥6,791M |
| Efficiency | ||||
| ROE | 9.23% | 10.14% | 1.03% | 2.11% |
| ROA | 6.60% | 7.40% | 0.60% | 1.19% |
Latest IR Information
-
2026 1Q Financial Summary (Summary)
1Q results show substantial YoY increases in both revenue and profit, aligned with the company-wide growth strategy, supported by AI-related demand and expanded customer base, suggesting revisions and strengthening of the full-year outlook. Segments show solid growth in Control Components,...
Read more -
Q1 FY2027 IFRS Consolidated Financial Results (Interim) [IFRS]
For the first quarter of FY2027, consolidated net sales were 209,864 million yen, up 26.1% YoY, and operating income was 18,857 million yen, a substantial increase. The full-year guidance has been upwardly revised. By segment, IAB/external revenue remained solid, SSB...
Read more -
【Omron】Completed Share Buyback｜Results as of June 2026
Omron Healthcare has completed the purchase of 18,459,288 shares of the target company, increasing the voting rights ratio to 95.88%.
Read more -
【Omron】2026 Financial Results and Share Buyback｜Sales Unavailable, Share Acquisition Completed in May 2026
Omron announced a net profit of 1,549,955 thousand yen for the fiscal year ending March 2026, with sales figures unavailable, and plans to commence a share buyback from May 19, 2026. The maximum purchase amount exceeds 2.04 billion yen, with...
Read more -
Notice Regarding Company Split (Absorption-type Split) of Device & Module Solutions Business and Share Transfer of the Successor Company (Change of Subsidiaries)
OMRON Corporation will transfer its Device & Module Solutions business to a successor company through an absorption-type split effective July 1, 2026, and plans to transfer all shares of the successor company to TCG2602 Co., Ltd. on October 1, 2026.
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥5,673
Rating Score: 2.55 (Based on 11 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
OMRON Corporation engages in industrial automation, device and module solutions, data solutions, social systems, and healthcare businesses in Japan and internationally. The company operates through industrial automation, healthcare, social systems, device and module solutions, and data solution. It provides sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products. The company also offers environmental mobility, digital devices, food and daily necessities, logistics and warehouse automation, medical, robotic, panel, vision, software, and traceability solutions. In addition, it provides power storage systems; station systems, such as automatic ticket gates and ticket vending machines, traffic control systems, and payment systems; and data and power protection systems comprising UPS, as well as software development and maintenance services. Further, the company offers cardiovascular, respiratory care, pain management, remote patient monitoring, and other solutions. Additionally, it provides relays, switches, connectors, and sensors. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.
